-
Research
- Experts
In The News
View All
Regenstrief Vice President for Data and Analytics, Shaun Grannis, M.D., M.S., discussed the latest on Monkeypox and how it’s spread.
Read MoreInfluence
View All
‘Memory loss is not normal aging’ — Regenstrief scientist highlights challenges of living with dementia
Regenstrief Institute Research Scientist NiCole Keith, PhD, addressed the many...
Read More- Opportunities
Featured Fellowship
View all
HSR Fellowships & Training
The VA Health Services Research & Development Center for Health Information...
Read More- About
- The Latest
- Experts
LOINC® issues new monkeypox, COVID and other concepts; adds Ukrainian translation
Facilitates interoperability needed for health information exchange LOINC® from Regenstrief Institute is issuing its semiannual content update with 811 new concepts to help health systems, laboratories
Research team awarded more than $10 million to improve cognitive recovery of post-operative delirium survivors
An interdisciplinary team from University of Wisconsin School of Medicine and Public Health, Regenstrief Institute and Indiana University School of Medicine will evaluate the effectiveness
OpenHIE to host virtual community meeting over 3 days in September
OpenHIE will host a virtual community meeting over three interactive days, September 13, 15 and 21, 2022. The meeting, “The Journey from Plans to Practice,”
Staff and facility administrator retention has been challenging for long-term care facilities
Continuity of care important for vulnerable population that resides in nursing homes The pandemic has called attention to an issue that nursing home residents, their
LOINC® from Regenstrief returns to in-person learning with conference in Annecy, France
On-site attendance encouraged for most valuable experience LOINC® from Regenstrief Institute, a global healthcare terminology standard, is returning to in-person learning at its semi-annual conference October
Pharmacist-based deprescribing successfully reduced older adults’ exposure to anticholinergic drugs
Anticholinergics, a class of drugs frequently prescribed for depression, urinary incontinence and many other conditions common in older adults, affect the brain by blocking acetylcholine,
Caregiver engagement enhances health outcomes of chronically ill adults
New meta-analysis of studies spanning three decades provides compelling evidence of caregivers’ value across healthcare transitions Led by Regenstrief Institute Research Scientist Kristin Levoy, PhD,
Second mRNA booster significantly effective against Omicron variants
In one of the first investigations of the effectiveness of a second mRNA booster against COVID-19 Omicron variants, a study from the U.S. Centers for
Innovative tool targets avoidable hospitalizations of nursing home residents with existing nursing home EHR information
The Avoidable Transfer Scale, an innovative tool that uses data commonly included in a nursing home resident’s electronic medical record to identify and characterize potentially
Regenstrief Institute and IU receive 5-year continuation of funding for public and population health informatics training program
Regenstrief Institute and Indiana University have received a second five years of support from the National Library of Medicine (NLM), part of the National Institutes